Three Arch Partners
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as
Business Model:
Revenue: $7.3M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Three Arch Partners Information
Geographic Data
Address: 3200 Alpine Rd
City: Portola Valley
State: CA
Zip: 94028
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Contact Phone:
+16505298000
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2003 | VisionCare Ophthalmic Technologies | Series B | 6.8M |
| 4/2003 | iScience Interventional | Series C | 15M |
| 3/2007 | SquareOne | Series C | 0 |
| 11/2002 | Coalescent Surgical | Series D | 0 |
| 6/2002 | Novare Surgical | Series C | 9.8M |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 6/2010 | Calistoga Pharmaceuticals | Series C | 40M |
| 3/2007 | Calistoga Pharmaceuticals | Series A | 21M |
| 5/2007 | Arete Therapeutics | Series A | 35M |
| 6/2011 | Crux Biomedical | Series C | 12M |
| 9/2004 | Vascular Architects | Series E | 0 |
| 1/2008 | Calistoga Pharmaceuticals | Series A | 5.2M |
| 8/2002 | Threshold Pharmaceuticals | Series A | 8.3M |
| 9/2004 | Allux Medical | Series A | 800k |
| 8/2000 | Epocrates | Series B | 35M |
| 12/2005 | Oculir | Series A | 7.3M |
| 8/2002 | Epocrates | Series C | - |
| 1/2012 | Access Closure | Venture Round | 0 |
| 2/2007 | Visiogen | Venture Round | 24M |
| 1/2002 | Opus Medical | Series B | 2.1M |
| 4/2007 | iScience Interventional | Series E | 20M |
| 5/2007 | Pegasus Biologics | Series C | 20M |
| 3/2006 | Reliant Technologies | Series D | 22M |
| 5/2007 | NeuroVista | Series B | 33.8M |
| 10/2010 | TriReme Medical | Series D | 17M |
| 10/2011 | Salveo Specialty Pharmacy | Series A | - |
| 8/2002 | Concuity | Series C | 16.3M |
| 10/2009 | Neuronetics | Series D | 0 |
| 8/2006 | Neuronetics | Series C | 0 |
| 8/2010 | Respicardia | Series C | 0 |
| 10/2012 | Access Closure | Venture Round | 0 |
| 1/2005 | Reliant Technologies | Series C | 7M |
| 11/2011 | Inova Labs | Series B | 0 |
| 11/2003 | VisionCare Ophthalmic Technologies | Series C | 12.4M |
| 7/2007 | Satiety | Series D | 30M |
| 12/2004 | NeuroBionics | Series A | 6M |
| 5/2009 | Calistoga Pharmaceuticals | Series B | 30M |
| 8/2003 | LipoScience | Series E | 15M |
| 2/2004 | Reliant Technologies | Series B | 12.9M |
| 7/2002 | Opus Medical | Series B | 6.5M |
| 7/2002 | Visiogen | Series B | 5M |
| 6/2003 | Opus Medical | Series C | 13.6M |
| 11/2009 | Calibra Medical | Venture Round | 1.4M |
| 1/2011 | VisionCare Ophthalmic Technologies | Series E | 0 |
| 1/2004 | Threshold Pharmaceuticals | Series B | 41M |
| 7/2008 | Eleme Medical | Series C | 0 |
| 11/2007 | SquareOne | Series C | 8M |
| 6/1997 | Spinal Dynamics | Series A | - |
| 3/2005 | Confluent Surgical | Series D | 0 |
| 3/2004 | Coalescent Surgical | Series E | 2M |
| 3/2011 | Tibion Bionic Technologies | Series B | 0 |
| 5/2007 | Pegasus Biologics | Series C | 20M |
| 5/2009 | iScience Interventional | Series F | 20.5M |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 1/2003 | Vascular Architects | Series D | 0 |
| 4/2007 | Aspen MedTech | Venture Round | 1M |
| 8/2006 | LipoScience | Series F | 13M |
| 2/2009 | SpinalMotion | Venture Round | 500k |
| 3/2005 | Sirtris Pharmaceuticals | Series B | 27M |
| 4/2006 | Sirtris Pharmaceuticals | Series C | 37M |
| 7/2004 | LipoSonix | Series C | 27M |
| 10/2007 | TriReme Medical | Series C | 15.5M |
| 3/2005 | SpinalMotion | Series B | 20.1M |
| 3/2007 | SmoothShapes | Series B | 15M |
| 3/2010 | Access Closure | Venture Round | 10M |
| 3/2005 | iScience Surgical | Series C | 0 |
| 9/2008 | Baxano | Series B | 20M |
| 10/2004 | Concuity | Venture Round | 8.3M |
| 7/2002 | Transvascular | Series D | 10.8M |
| 12/2006 | NBI Development | Seed Round | 5.5M |
| 8/2008 | Calibra Medical | Series B | 35M |
| 3/2005 | Neuronetics | Series B | 8.5M |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 6/2002 | Spiration | Series D | 22M |
| 10/2005 | Radiant Medical | Venture Round | 36M |
| 4/2010 | Hemosphere | Series A | 9.3M |
| 12/2006 | Respicardia | Series A | 5.5M |
| 8/2008 | Voyage Medical | Series B | 22M |
| 6/2010 | Voyage Medical | Series C | 20.6M |
| 7/2004 | Vitra Bioscience | Venture Round | 5.5M |
| 1/2008 | North American Scientific | Venture Round | 15.5M |
| 9/2006 | Calibra Medical | Series A | 8.6M |
| 3/2007 | Ascend Health | Series B | 20.1M |
| 6/2010 | Baxano | Series C | 30M |
| 1/2012 | iScience Interventional | Venture Round | 2.8M |
| 12/2006 | Nevro | Seed Round | 5.5M |
| 3/2008 | Spiration | Series G | 18.5M |
| 11/2003 | The Center from Health Promotion | Venture Round | 10M |
| 5/2011 | Neuronetics | Series E | 30M |
| 7/2011 | Nevro | Series B | 58M |
| 1/2001 | Phylos | Series B | 25M |
| 7/2010 | Ingenuity Systems | Venture Round | 15.4M |
| 9/2008 | Nevro | Series A | 21.8M |
| 6/2017 | Neuronetics | Series G | 0 |
| 1/2010 | Free &a; Clear | Venture Round | 10M |
| 4/2015 | Neuronetics | Series F | 0 |
| 4/2008 | Concert Pharmaceuticals | Series C | 0 |
| 5/2004 | Evalve | Series C | 0 |
| 9/2008 | APT Pharmaceuticals | Series B | 32M |
| 4/2006 | Spiration | Series F | 13.4M |
| 10/2008 | Respicardia | Series B | 0 |
| 6/2008 | Cameron Health | Series E | 0 |
| 1/2004 | Spiration | Series E | 0 |
| 3/2002 | Novacept | Venture Round | 30M |
| 3/2013 | Nevro | Series C | 0 |
| 11/2013 | Ocera Therapeutics | Post-IPO Equity | 0 |
| 7/2006 | Concert Pharmaceuticals | Series A | 10M |
| 1/2007 | AcuFocus | Series D | 0 |
| 3/2000 | MEDCHANNEL | Series B | 42M |
| 12/2002 | VetCentric | Venture Round | 14.5M |
| 5/2009 | Visiogen | Series D | 40M |
| 4/2007 | Reliant Technologies | Series E | 15M |
| 1/2005 | VisionCare Ophthalmic Technologies | Series D | 20M |
| 12/2003 | Visiogen | Venture Round | 16.5M |
| 5/2008 | Novasys Health | Venture Round | 49.5M |
| 4/2005 | Allux Medical | Series B | 5M |
| 1/2008 | Benvenue Medical | Series B | 15M |
| 11/2003 | Cameron Health | Series B | 29M |
| 5/2008 | Novasys Medical, Inc. | Series D | 49.5M |
| 10/2005 | Cameron Health | Series C | 15M |
| 11/2012 | MEI Pharma | Post-IPO Equity | 27.5M |
| 11/2006 | Concert Pharmaceuticals | Series B | 48.5M |
| 7/2006 | Cameron Health | Series D | 31M |
| 4/2006 | Concuity | Series E | 2.5M |
| 1/2004 | NeuroVista | Series A | 7.3M |
| 6/2017 | Neuronetics | Series G | 0 |
| 4/2015 | Neuronetics | Series F | 0 |
| 11/2013 | Ocera Therapeutics | Post-IPO Equity | 0 |
| 3/2013 | Nevro | Series C | 0 |
| 11/2012 | MEI Pharma | Post-IPO Equity | 0 |
| 10/2012 | Access Closure | Venture Round | 0 |
| 1/2012 | iScience Interventional | Venture Round | 0 |
| 1/2012 | Access Closure | Venture Round | 0 |
| 11/2011 | Inova Labs | Series B | 0 |
| 10/2011 | Salveo Specialty Pharmacy | Series A | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
